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Abstract
Background: Normal growth and development of organisms requires maintenance of a dynamic
balance between systems that promote cell survival and those that induce apoptosis. The molecular
mechanisms that regulate these processes remain poorly understood, and thus further in vivo study
is required. Survivin is a member of the inhibitor of apoptosis protein (IAP) family, that uniquely
also promotes mitosis and cell proliferation. Postnatally, survivin is hardly detected in most tissues,
but is upregulated in all cancers, and as such, is a potential therapeutic target. Prenatally, survivin is
also highly expressed in several tissues. Fully delineating the properties of survivin in vivo in mice
has been confounded by early lethal phenotypes following survivin gene inactivation.
Results: To gain further insights into the properties of survivin, we used the zebrafish model.
There are 2 zebrafish survivin genes (Birc5a and Birc5b) with overlapping expression patterns during
early development, prominently in neural and vascular structures. Morpholino-induced depletion
of Birc5a causes profound neuro-developmental, hematopoietic, cardiogenic, vasculogenic and
angiogenic defects. Similar abnormalities, all less severe except for hematopoiesis, were evident
with suppression of Birc5b. The phenotypes induced by morpholino knockdown of one survivin
gene, were rescued by overexpression of the other, indicating that the Birc5 paralogs may
compensate for each. The potent vascular endothelial growth factor (VEGF) also entirely rescues
the phenotypes induced by depletion of either Birc5a and Birc5b, highlighting its multi-functional
properties, as well as the power of the model in characterizing the activities of growth factors.
Conclusion: Overall, with the zebrafish model, we identify survivin as a key regulator of
neurogenesis, vasculo-angiogenesis, hematopoiesis and cardiogenesis. These properties of survivin,
which are consistent with those identified in mice, indicate that its functions are highly conserved
across species, and point to the value of the zebrafish model in understanding the role of this IAP
in the pathogenesis of human disease, and for exploring its potential as a therapeutic target.
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For normal homeostasis in multicellular organisms, there
exists a delicate balance between cell proliferation and cell
death, maintenance of which is required to prevent path-
ological outcomes including developmental abnormali-
ties, cancer, autoimmune diseases, degenerative disorders
and poor outcome following wounds and ischemic
injury. The major physiologic means by which cell death
is achieved in an organism is via apoptosis, a tightly regu-
lated and highly conserved process. In spite of major gains
in characterizing the apoptotic pathways in vitro, a better
understanding of the precise cellular mechanisms of
apoptosis in different tissues and developmental time
points in vivo is still required.
The inhibitor of apoptosis proteins (IAPs) are a family of
conserved caspase inhibitors originally identified in bacu-
loviruses as proteins capable of preventing virus-mediated
cell death in insect cells. Survivin is the smallest of the
human inhibitor of apoptosis proteins (IAPs), and has
several unique features (reviewed in [1]). It possesses one
baculovirus IAP repeat (BIR) domain that is essential for
caspase interference, and contains a C-terminal alpha-hel-
ical coiled-coil domain [2] that is important for mitosis.
Survivin functions as a chromosome passenger protein,
complexing with aurora B, borealin and INCENP [3]. Sur-
vivin also promotes cell cycle progression [4], and is
highly expressed by proliferating cells, while being barely
detectable in quiescent adult tissues [5]. Its uniformly ele-
vated expression in essentially all cancers has rendered
survivin a therapeutic target (reviewed in [6,7]), and thus
a critical understanding of the properties of survivin is key
for its successful introduction into the clinic.
In both humans and mice, there is a single survivin gene
that generates several different protein products due to
alternative pre-mRNA splicing (reviewed in [8]). Trans-
genic mouse studies revealed that the major, full-length
form of survivin is crucial for normal leukocyte [9] and
hepatocyte function [10], hematopoiesis [11], and opti-
mal angiogenic response to injury [2,8,12]. Elucidating its
developmental role has been limited by the fact that sur-
vivin gene inactivation in mice causes early embryonic
lethality [3,10]. Nonetheless, conditional gene inactiva-
tion studies indicate that survivin is essential for brain
development [13], angiogenesis and cardiogenesis [14].
In Xenopus laevis, there are 2 survivin genes, overexpression
of one which induces endothelial proliferation [15], while
augmented expression of the other had inexplicably lethal
effects. Danio rerio (zebrafish) also have 2 survivin genes.
Ma et al [16] reported that survivin is important in angio-
genesis during zebrafish development, but these studies
were limited, as the authors did not examine early devel-
opmental time points, they restricted their analyses to
only one of the genes, and they did not evaluate the
importance of survivin in other organ systems.
To gain further insights into the developmental role of
survivin, we used the zebrafish model and detailed the
spatio-temporal expression patterns of the 2 survivin genes
and characterized their functions. Zebrafish survivin 1
(Birc5a) and survivin 2 (Birc5b) both prevent apoptosis
and promote cell proliferation. While they have overlap-
ping patterns of distribution and function, Birc5a pre-
dominates in most systems. Consistent with its role in the
mouse, both zebrafish survivin genes play critical roles in
regulating developmental vasculogenesis, angiogenesis,
neurogenesis, cardiogenesis, valvulogenesis and hemat-
opoiesis. The model highlights the conservation of sur-
vivin's functions across species, and points to the
relevance of utilizing the zebrafish model to evaluate its
mechanisms of action, findings that may be extrapolated
to human disease.
Results
Orthologues of Survivin in zebrafish
A BLAST search for orthologues of human survivin in
zebrafish revealed 2 survivin genes (Birc5a and Birc5b)
located on chromosomes 12 and 23, respectively. Using
the CLUSTAL W program, the putative predicted proteins
were aligned with the orthologous proteins found in
human, mouse, Xenopus laevis and Xenopus tropicalis
(Additional file 1A). Human survivin is 142 amino acids
long, comprised of a 15 amino acid N-terminal domain, a
BIR domain (amino acids 16–87), and a C-terminal
coiled-coil domain. The proteins encoded by Birc5a and
Birc5b exhibit 45–55% overall similarity with those from
other species and with each other (Additional file 1B). The
greatest sequence conservation between Birc5a and Birc5b
resides in the BIR domain (79% similarity). From compu-
ter analysis (COILS: http://www.ch.EMBnet.org/software/
COILS_form.html), the C-terminal domains of the
zebrafish survivin proteins do not form coiled-coil alpha-
helical structures, a region that in murine survivin, inter-
acts with the mitotic spindle.
Expression patterns of Birc5a and Birc5b
Ma et al [16] previously described expression of Birc5a in
26 hpf zebrafish embryos restricted to the developing
brain, neural tube, and in cells surrounding the axial ves-
sels. We performed detailed studies of the expression pat-
terns of both Birc5a and Birc5b by in situ hybridization
using gene-specific probes (Additional file 2). The 2 genes
entirely overlap in their spatio-temporal patterns of expres-
sion. Since there are no prior reports on the expression of
Birc5b in the zebrafish embryo, we therefore only provide
images for Birc5b (Figure 1). Birc5a and Birc5b were
detected as maternal messages throughout the embryo 1
hour post fertilization (hpf) (not shown). Similar to the
report by Ma et al [16] for Birc5a, by 20–24 hpf (20–30
somites), expression of both genes was prominent in neu-
ral tissues, including the entire brain, neural tube, the floor
plate, and the midbrain-hindbrain barrier (Figure 1A, B). InPage 2 of 17
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Birc5b spatiotemporal expression in zebrafish embryosFigure 1
Birc5b spatiotemporal expression in zebrafish embryos. A, B. Lateral (A) and dorsal (B) views of 20 hpf (20 somites) 
embryos revealing expression of Birc5b in the neural tube, brain, pronephric duct and eyes. C. Lateral view 1 dpf (30 somites) 
embryo, showing Birc5b expression in brain, eye, neural tube, somite and intersomite boundaries, with higher magnification in 
D. E. Transverse section through 1 dpf embryo (from C), revealing expression of Birc5b in neural tube, somites and caudal vein 
plexus. F. Dorsal view of head region of 2 dpf embryo. Birc5a detected in brain, floor plate and branchial arches. G. Diagram of 
2 dpf embryo with transverse sections in panels H and I. Transverse sections through 2 dpf embryo reveals expression in ret-
ina and iris (H), floor plate, dorsal aorta, posterior cardinal vein; not in somite (I). J-L. Lateral (J) and dorsal (K, L) views of 3 
dpf embryo; expression of Birc5b at midbrain-hindbrain barrier, branchial arches and eyes; not in region of axial vessels, somites 
or intersomite boundaries (L). nt: neural tube, p: pronephric duct, b: brain, e: eye, rt: retina, I: iris, mh: midbrain-hindbrain bar-
rier, fp: floor plate, ba: branchial arches, s: somite, sb: intersomite boundary, da: dorsal aorta, pcv: posterior cardinal vein, cv: 
caudal vein plexus.
BMC Developmental Biology 2009, 9:25 http://www.biomedcentral.com/1471-213X/9/25contrast to the report of Ma et al, at 1 dpf, we also found
Birc5 expression in the ventral somites, at the somite
boundaries, and in the caudal vein plexus, and in the eye
(Figure 1B–E). Although evident from 20 hpf, at 2 dpf,
there was more prominent expression of both Birc5 tran-
scripts in the lens and retina of the eyes, in the major axial
vessels, and in the branchial arch primordia (Figure 1F–I).
Notably, by 2 dpf, expression in the somites was almost
absent (Figure 1I). By 3 dpf, both Birc5 transcripts were
detected in all the branchial arches, in brain, at the mid-
brain-hindbrain boundary, in the eyes, but was almost
entirely absent in the axial vessels and somites (Figure 1J–
L). Overall, the expression patterns of the two zebrafish sur-
vivin genes are indistinguishable during development, and
are predominantly localized to neural, vascular and ocular
structures, with transient expression in the somites and
axial vessels during their formation.
Zebrafish Birc5 morpholino knockdowns
To assess the functions of Birc5a and Birc5b, we used mor-
pholinos to knock down each of the genes. Morpholinos
were selected to target sites within each orthologue with
the most sequence divergence, including the start codon
(ATG morpholinos). Specificity of ATG morpholinos was
confirmed by also using morpholinos that target pre-
mRNA splice sites or 5' UTR regions (Additional file 3).
Controls were performed by injecting a mismatch mor-
pholino (GeneTools, Philomath, Oregon, USA). Each
morpholino dose was tested on at least 100 embryos. All
morpholinos (ATG, splice site and UTR) for one gene gave
identical phenotypes; the results reported reflect those
with ATG-morpholinos. We additionally confirmed gene-
specificity by in vitro transcription-translation studies.
Even at high doses, Birc5a morpholinos had no effect on
Birc5b expression, and similarly, Birc5b morpholinos did
not affect Birc5a expression (Additional file 4[17,18]).
Finally, in all studies, we excluded p53-mediated off-tar-
get effects on apoptosis and the observed survivin mor-
pholino-induced phenotypes, by co-injecting p53
morpholinos, as described [19] (data not shown).
Birc5 in neural development
Birc5a and Birc5b morpholino-injected wild-type AB
embryos were assessed by brightfield microscopy (Figure
2). After injection of 0.5 ng Birc5a morpholino, morphant
embryos at 1 dpf (Fig 2A, B) and 2 dpf (Fig 2D, E) dis-
played microcephaly (42%, n = 162 at 1 dpf; 57%, n = 157
at 2 dpf) with fluid accumulation in the 4th ventricle (Fig
2E). The effects of Birc5b depletion on brain development
using the highest morpholino dose were less dramatic
than with the Birc5a knockdown, with 10–15% of Birc5b
morphants exhibiting microcephaly at 1 dpf (n = 143)
and 2 dpf (n = 105) (Figure 2C, F).
Disturbances in neuronal development were, however,
more readily detectable in both Birc5a and Birc5b mutants
by in situ hybridization with probes to detect Zic1, a pan-
neural marker [20] (Figure 2G–I), and Islet1, a marker of
primary motor neurons [21] (Figure 2J–L). Zic1 staining
of the brain was decreased in the 2 dpf Birc5a morphants
as compared to controls, reflecting the almost total
absence of neural cells. The reduction was also evident in
the Birc5b morphants, to a lesser extent when compared to
the Birc5a morphant. Similarly, islet1 staining of the
Birc5a morphants revealed disorganized or absent motor
neurons, while the Birc5b morphants were also affected,
but again, less severely.
Overall, both Birc5 genes are critical for normal neural
development, with Birc5a predominating.
Birc5 in vasculogenesis and angiogenesis
Recently, Ma et al [16] reported that Birc5a knockdowns
primarily induce angiogenic abnormalities, but without
affecting vasculogenesis. We extended on their work by
examining vasculo-angiogenesis in Birc5a and Birc5b
knockdown embryos at different developmental time
points, using Tg(Fli:eGFP) or Tg(Flk1:GFP) embryos
(Zebrafish International Resource Center [22]) which
express green fluorescent protein (GFP) in endothelial
cells (Figure 3).
Precursor angioblasts in zebrafish arise at 12 hpf (6
somites) in the lateral plate mesoderm and migrate from
14 hpf (10 somites) toward the midline, where they coa-
lesce to form primary axial vessels [22]. We first estab-
lished that depletion of Birc5a or Birc5b does not induce a
defect in mesodermal development, by determining that
expression of the mesodermal marker, no tail (ntl) [23] in
both morphants at 6 hpf, as compared to control
zebrafish embryos, was not different (not shown).
We then studied the effect of depleting Birc5a and Birc5b
with the highest morpholino doses (2 ng and 4 ng, respec-
tively) on vasculogenesis and angiogenesis. At 16 hpf (14
somites), Birc5a morphant angioblasts migrated in a disor-
ganized fashion, at different rates, with some remaining at
the lateral plate mesoderm (Figure 3A, B). Angioblasts in
Birc5b morphants migrated normally to the midline at 16
hpf (Figure 3C), but there was reduced signal intensity and
thickness of the coalescing axial vessels (22% of embryos, n
= 147). With depletion of Birc5a, the dorsal aorta and pos-
terior cardinal vein at 1 dpf and 2 dpf were thinner (45–
52%), with a smaller caudal vein plexus (45–52%) (Figure
3D, E, G, H, J, K). A similar effect, although not as promi-
nent and not involving the posterior cardinal vein, was also
evident in Birc5b morphants (Figure 3F, I, L). The findings
were better visualized following in situ hybridization of 1
dpf embryos with probes flt4 and gridlock (grl) that detect
the posterior cardinal vein and the dorsal aorta/intersom-
itic vessels, respectively [24] (Figure 3M–R). The Birc5a
morphants also exhibited delayed sprouting of intersomiticPage 4 of 17
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Birc5 in neurodevelopmentFigure 2
Birc5 in neurodevelopment. Brightfield microscopy of AB zebrafish embryos. A-F: Embryos oriented with head to left. Lat-
eral views at 1 dpf (A, B, C) and 2 dpf (D, E, F), the latter being higher power views of head region. Depletion of Birc5a results 
in lack of brain development, revealed at 1 dpf (B, arrow) and 2 dpf (E, arrow), with fluid in 4th ventricle, compared to controls 
(A, D). At 2 dpf, Birc5a knockdown causes cardiogenic defects and pericardial edema (E, double arrow), not observed in con-
trols (D). Majority of Birc5b depleted embryos do not exhibit phenotypic abnormalities under brightfield microscopy at 1 dpf 
(C) compared to controls (A). At 2 dpf, Birc5b knockdown embryos have smaller head and brain, and accumulate blood in the 
sinus venosus (F, arrow). Zic1 expression to detect neural tissue, is decreased by Birc5a depletion (H, arrow), compared to 
controls (G). A similar but less dramatic diminution of Zic1 expression is observed with morpholino knockdown of Birc5b (I, 
arrow). Depletion of Birc5a also induces disorganization of motor neurons, detected by expression of islet1 (K, arrow), com-
pared to controls (J). Birc5b morphants exhibit less severe but still evident, suppression of islet1 expression (L, arrow).
BMC Developmental Biology 2009, 9:25 http://www.biomedcentral.com/1471-213X/9/25vessels (ISVs), which were occasionally absent, but other-
wise were often thin, misdirected, lacking connections, and
associated with interruption of the dorsal longitudinal
anastomotic vessels. These findings, in concert with the fact
that Birc5 expression was transiently detected at the somite
boundaries, suggests a role for survivin in ISV patterning
and vessel guidance (reviewed in [25]). Interestingly and in
contrast, formation of the intersomitic vessels and dorsal
longitudinal anastomotic vessels remained intact in the
Birc5b morphants.
By 3 dpf, there was underdevelopment and irregular pat-
terning of cranial blood vessels of both the Birc5a and
Birc5b morphants (see Additional Files 5, 6, 7) as compared
with controls. Only 1 of the branchial arches was seen in
the majority of the Birc5a morphants (61%) (Figure 3S, T),
while the 5th and 6th branchial arches in the Birc5b mor-
phants were either absent or hypoplastic (65%) (n = 160)
(Figure 3U). In attempting to explain the branchial arch
defects, we performed in situ hybridization studies at 2 dpf
with crestin, a post migratory neural crest cell marker [26].
In both the Birc5a and the Birc5b morphants, but more
prominent with depletion of Birc5a, there were fewer cres-
tin-positive neural crest cells in the region of the neural
crest, corresponding to that which is critical for develop-
ment of the branchial arches [27] (Figure 3V–X).
In summary, both Birc5 genes are important for normal
vasculogenesis, angiogenesis, and vascular patterning.
Although the 2 genes functionally overlap, again, Birc5a
appears to play a more prominent role.
Birc5 in hematopoiesis
Since, in the zebrafish, at least a subset of hematopoietic
and endothelial lineages arise from a common heman-
gioblast [28], we also examined Birc5a and Birc5b mor-
phants for defective hematopoiesis. Erythrocytes in 3 dpf
embryos were identified by staining for hemoglobin with
o-dianisidine. Depletion of Birc5a or Birc5b resulted in a
reduced number of erythrocytes in the ducts of Cuvier
(Figure 4A–C). Moreover, gata1 expression, reflecting
hematopoiesis at 1 dpf, was reduced in 35% of Birc5a
morphants (n = 112), and 28% of Birc5b morphants (n =
115), as compared to controls (n = 70) (Figure 4D–F).
Since defects in circulation may impact on the preceding
findings, we examined hematopoiesis at 14 hpf, prior to
development of a functional circulation. Flow cytometry
of cellular suspensions of dechorianated Tg(gata1:GFP)
embryos was used to quantify the number of Gata1+ cells
relative to the total number of cells [29]. Depletion of
either Birc5a or Birc5b, as compared to control injections,
resulted in a decrease in the absolute number of Gata1+
cells from 3.37% for controls to 0.72% for Birc5a, and to
0.42% for Birc5b. In line with these findings, expression of
hematopoietic genes gata1, scl and Imo2 [29], quantified
by real-time PCR at 14 hpf and 18 hpf in AB zebrafish
embryos, was significantly reduced (p < 0.01) by deple-
tion of either Birc5a or Birc5b. Overall, the data support a
role for both Birc5 genes in promoting hematopoiesis in
the developing zebrafish embryo.
Birc5 in cardiogenesis
Depletion of either Birc5a or Birc5b resulted in cardiovas-
cular defects. At the highest morpholino dose, one third
of Birc5a morphants displayed pericardial edema, while
blood flow in the dorsal aorta and posterior cardinal vein
was slowed or absent in at least half the embryos. The
heart rate in both Birc5a and Birc5b morphants was signif-
icantly reduced (60 ± 8, 56 ± 8, and 86 ± 7 beats/minute
in Birc5a morphants, Birc5b morphants, and controls,
respectively; p < 0.001 versus controls). In situ hybridiza-
tion at 30 hpf with the ventricle and cardiac-specific mark-
ers, ventricle myosin heavy chain (vmhc) and cardiac
myosin light chain (cmlc2) [30], respectively, demon-
strated that Birc5a morphant ventricles and hearts were
smaller than controls (41%, n = 24 for vmhc; 42%, n = 76
for cmlc2) (Figure 5A, B, D, E). Although not as striking,
Birc5b morphants also exhibited smaller ventricles and
hearts at 30 hpf (Figure 5C, F) (26%, n = 31 for vmhc;
32%, n = 89 for cmlc2). At 48 hpf when atrio-ventricular
(a-v) valve formation is underway, bone morphogenic
protein 4 (bmp4) [31] transcripts progressively localize
from the atrium and ventricle to myocardial cells at the
valve-forming region [32]. With Birc5a depletion, redistri-
bution of bmp4 did not occur in 38% (n = 62) of embryos
(Figure 5G, H), predicting defects in valvulogenesis. This
was evident in hematoxylin and eosin (H&E) stained sec-
tions of 4 dpf embryos, where there was little evidence of
an a-v valve in the Birc5a morphants, at a time when the
myocardial layer of the morphant ventricle was also thin-
ner, as compared to control embryos (Figure 5J, K). In the
Birc5b morphants, bmp4 became localized to the a-v valve,
similar to controls, although the opening was smaller in
21% (n = 44) (Figure 5I). At 4 dpf, H&E stained sections
also revealed smaller cardiac chambers (20%) (Figure 5L).
Although diminished vascular perfusion may contribute
to cardiogenic defects [33], we hypothesized that an addi-
tional factor in the Birc5 morphants might be altered for-
mation and/or migration of cardiac neural crest cells, a
site of origin of cardiomyocytes in zebrafish [34].
Embryos at 15.5 hpf (13 somites) were therefore hybrid-
ized with the foxd3 probe to stain premigratory neural
crest cells [35]. Birc5a depletion caused cardiac neural
crest cell loss along the rostrocaudal axis (Figure 5M, N),
particularly in the region critical for formation of the ven-
tricle, a-v junction, and atrium (region referred to as
"Group B" by Sato et al [36]). Birc5b depletion also
resulted in loss of cardiac neural crest cells – again, not as
dramatically as with Birc5a depletion (Figure 5O).
Overall, the findings indicate that Birc5a- and Birc5b-
dependent signals are important in maintaining the integ-Page 6 of 17
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Birc5 in vasculogenesis and angiogenesisFigure 3
Birc5 in vasculogenesis and angiogenesis. Tg(Fli:eGFP) (A-L) and Tg(Flk1:GFP) (S-U) embryos. A-C: 16 hpf (14 somites), 
Birc5a morphants with angioblast migration defects from lateral plate mesoderm (B) which are minor in Birc5b morphants (C). 
D-F: 1 dpf, Birc5a (E, H) and Birc5b (F, I) morphants have thinner axial vessels and poor caudal vein plexus development. G-I: 1 
dpf Birc5a depletion (H) delays intersomitic vessels; not with Birc5b depletion (I). J-L: 2dpf Birc5a morphants with abnormal dor-
sal longitudinal anastomic and intersomitic vessels. Both morphants have poorly developed caudal vein plexus. M-O: flt4 at 1 
dpf is reduced in posterior cardinal vein in both morphants (N, O). P-R: gridlock (grl) at 1 dpf is reduced with Birc5a depletion 
(Q), but not with Birc5b (R). S-U: 3 dpf Birc5a morphants have hypoplastic aortic arches (T). Birc5b depletion at 3 dpf causes 
hypoplasia of aortic arches 5–6 (U). V-X: Birc5a depletion decreases neural crest cells that migrate to branchial arches, 
detected with crestin probe. Birc5b depletion (L) reduces neural crest cells. ax: axial vessels, mhc: midbrain-hindbrain channel, 
Se: intersomitic vessels, aa: aortic arch, cv: caudal vein plexus, pcv: posterior cardinal vein, da: dorsal aorta, dlav, dorsal longitu-
dinal anastomic vessel, Ha: hypobranchial artery, va: ventral aorta, lpm: lateral plate mesoderm.
BMC Developmental Biology 2009, 9:25 http://www.biomedcentral.com/1471-213X/9/25rity of cardiac neural crest cells that in turn, contribute to
normal cardiogenesis and valvulogenesis.
Birc5 knockdowns result in increased apoptosis and 
decreased cell proliferation
Ma et al [16] reported that depletion of Birc5a caused
increased apoptosis primarily in the neural tube and
brain. Given the diverse pro-survival properties of sur-
vivin, we assessed the mechanisms of action of each
zebrafish survivin gene in the neural and vascular systems.
TUNEL staining of normal Tg(Fli:eGFP) embryos at 1 dpf
(Figure 6, left column) and 2 dpf (not shown) revealed
minimal evidence of apoptosis. In contrast, at a mor-
pholino dose of 2 ng, Birc5a morphants exhibited signifi-
cant apoptosis, mostly in the brain and spinal cord
(Figure 6A, B, D, E), with lesser amounts in the region of
the axial vessels and caudal vein plexus (Figure 6E, H).
TUNEL staining in the Birc5b morphants at 1 dpf was, by
comparison, less in the neural tissues, but more promi-
nent in the region of the caudal vein plexus and axial ves-
sels (Figure 6C, F). With both gene knockdowns,
apoptosis remained spatially unchanged, but was
increased at 2 dpf (not shown).
Quantification of TUNEL positive cells in the caudal vein
plexus and the corresponding dorsal neural tube region
confirmed that depletion of either Birc5a or Birc5b at the
higher dose, caused a significant increase in the number of
apoptotic cells in both regions (p < 0.05) (Figure 6J–L).
However, when the Birc5a morpholino dose was
decreased to 0.5 ng, apoptosis in the caudal vein plexus
entirely resolved, while TUNEL staining in the neural tube
persisted (Figure 6M, N), indicating a greater sensitivity of
the neural structures to loss of Birc5a. Conversely, as the
Birc5b morpholino dose was decreased, the effect on the
neural tube diminished, while apoptosis in the region of
the caudal vein plexus persisted (Figure 6M, O).
We also quantified the effects of the two genes on cell pro-
liferation (Figure 7). At 1 dpf, proliferating cells were
present in the region of the caudal vein plexus and neural
tube (Figure 7A, B). Birc5a depletion using 2 ng of mor-
pholino interfered with cell proliferation in both regions,
while the 0.5 ng dose (Figure 7D, E) only suppressed pro-
liferation in the neural tube. Depletion of Birc5b also inter-
fered with cell proliferation in the caudal vein plexus and
neural tube, and this anti-proliferative effect in the neural
tube disappeared at the lower morpholino dose (Figure 7C,
F). Overall, the findings support the notion that both Birc5
genes interfere with apoptosis and promote cell prolifera-
tion during early zebrafish development, but that there are
dose-dependent and site-specific distinguishing features.
Phenotype rescues of Birc5a and Birc5b morphants
We determined whether we could rescue the Birc5 mor-
phants by co-injecting synthetic mRNAs encoding the
open reading frame of either Birc5a or Birc5b. In a dose-
Birc5 in hematopoiesisFigure 4
Birc5 in hematopoiesis. A-C: Depletion of Birc5a (B) or Birc5b (D) causes a reduction in erythropoiesis, shown by staining of 
erthrocytes with o-dianisidine (control, A). D-F: The preceding is consistent with decreased expression of gata1 by in situ 
hybridization in both gene knockdowns (E, F) as compared to control (D). ccv: common cardinal vein or duct of Cuvier, o-
dian.: o-dianisidine.Page 8 of 17
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Birc5 in cardiogenesisFigure 5
Birc5 in cardiogenesis. In situ hybridizations (A-I, M-O) and histologic sections (J-L) on AB embryos. A-C: At 30 hpf, expres-
sion of cardiac ventricle marker vmhc is reduced with Birc5a depletion (A, B), and to lesser extent in Birc5b morphants (C). D-
F: cmlc2 staining shows Birc5a (E) or Birc5b (F) morphants with impaired development of atrium and ventricle, compared to 
controls (D). G-I: At 48 hpf, bmp4 normally localizes in heart to reveal a ring-like structure, representing endocardial cushions 
of the atrio-ventricular valve (G, arrow). With depletion of Birc5a, bmp4 staining remains diffuse and ring structure is absent 
(H, arrow). In Birc5b-morphants, bmp4 localizes normally (I, arrow), but the ring is smaller. J-L: H&E stained histologic sections 
of hearts of normal embryos (J), and those depleted of Birc5a (K) and Birc5b (L) at 4 dpf. Birc5a morphants have thin-walled 
heart chambers, and little evidence of a-v valve formation. Birc5b-depleted embryos have smaller ventricles. M-O: Premigratory 
cardiac neural crest cells contributing to heart development, were detected by staining embryos at 15.5 hpf (13 somites) with 
foxd3. Compared to controls (M), premigratory neural crest cells were barely detectable in embryos depleted of Birc5a (N), 
and reduced in Birc5b morphants (O). a:atrium, v:ventricle.
BMC Developmental Biology 2009, 9:25 http://www.biomedcentral.com/1471-213X/9/25dependent manner, co-injection of the respective Birc5
mRNA almost entirely rescued both the vascular and neu-
ral phenotypes induced by the highest morpholino dose
(Table 1). Thus, at 2 dpf, the Birc5a morphants were res-
cued by co-injection of 1 ng of Birc5a mRNA, and the
Birc5b morphants were rescued by 1 ng of Birc5b mRNA.
Furthermore, co-injection of 1 ng of Birc5b mRNA could
also partially rescue the Birc5a morphants, while Birc5b
morphants could be completely rescued by Birc5a mRNA.
The findings indicate that the 2 survivin genes may, under
different conditions, compensate for each other.
Role of VEGF in regulating survivin
Vascular endothelial growth factor (VEGF) has vasculo-
angiogenic, neurogenic, cardiogenic and hematopoietic
properties, the effects on endothelial cells mediated in
part by upregulating survivin [37]. Ma et al [16] demon-
strated that VEGF protein upregulates expression of Birc5a
in zebrafish at 96 hpf. We evaluated whether VEGF could
rescue the phenotypes induced by depletion of the 2
zebrafish survivin genes. Human VEGF mRNA (500 pg) or
vehicle was injected into Tg(Fli:EGFP) embryos alone, or
with a control morpholino, or with maximum dose mor-
pholinos to deplete either Birc5a or Birc5b (Figure 8).
Embryos were evaluated at 2 dpf. In conjunction with
Birc5a morpholino knockdowns (n = 86), VEGF mRNA
reduced the incidence of neural and vascular defects to
43% and 37%, respectively, of that observed with Birc5a
morpholino alone. VEGF also rescued the phenotype
induced by Birc5b depletion. Thus, administration of
VEGF mRNA (n = 85) with Birc5b morpholino decreased
the incidence of vascular and neural defects in Birc5b mor-
phants (n = 110), to 20% and 24%, respectively, of that
found with Birc5b morpholino alone. The results demon-
strate that VEGF may protect the integrity of the neural
and vascular systems from single birc5 gene depletion,
possibly via a compensatory increase in expression of the
second birc5 gene.
Discussion and conclusion
In attempting to elucidate the physiologic relevance of the
inhibitor of apoptosis protein, survivin, we have utilized
the zebrafish model and characterized the expression pat-
terns and functions of its two genes in early development.
Our studies extend those of Ma et al [16], who first
reported that Birc5a has angiogenic, but not vasculogenic,
properties, a discrepancy that may be partly explained by
the fact that their studies were restricted to developmental
time points no earlier than 22 hpf. Several novel insights
are provided by our work. Both Birc5a and Birc5b are
expressed predominantly by neural, vascular, and ocular
structures, and in the somites/somite boundaries; both
inhibit apoptosis and promote cell proliferation; and
both contribute to normal vasculogenesis, angiogenesis,
cardiogenesis, neurogenesis and hematopoiesis. No other
member of the IAP family has been shown to have simi-
larly profound developmental effects on multiple organ
systems following gene inactivation or knockdown in
small animal models [38].
Our findings are consistent with immunohistochemical
analyses and survivin gene inactivation studies in the
mouse embryo, where the single survivin gene is essential
for survival, and also plays a key role in angiogenesis, neu-
rogenesis, cardiogenesis and hematopoiesis [5,11,13,14].
Our studies therefore support the concept that the
zebrafish paralogs, Birc5a and Birc5b, largely recapitulate
the properties of the ancestral gene, represented in the
mouse, thereby rationalizing the use of this model to elu-
cidate the role of survivin in health and disease in higher
animals.
While the two zebrafish survivin genes have indistinguish-
able patterns of expression during development, in all of
our assays, except those for hematopoiesis, depletion of
Birc5a resulted in more severe, and sometimes distinct
phenotypes. For example, only Birc5a depletion caused
marked alterations in ISV patterning. This phenotype
would be most readily attributed to expression of Birc5a at
the somite boundaries, where VEGF [39] and other guid-
ance molecules play a crucial role in vessel patterning
(reviewed in [25]). However, Birc5b is also expressed in
the somites/somite boundaries, and its depletion had no
effect on the ISVs. Thus, further studies, including analy-
ses of the expression profiles of relevant guidance mole-
cules, will be required to further elucidate the specific
properties of each Birc5 gene in the somites.
Functional differences between the two Birc5 genes were
additionally uncovered by titering the respective mor-
pholino doses to evaluate effects of each paralog on apop-
tosis and cell proliferation in the neural tube and vascular
structures. By this approach, Birc5a was found to be more
effective at protecting the neural structures, while Birc5b
was more effective at protecting the caudal vein plexus.
The latter is interesting, because the caudal vein plexus is
a major site for primitive hematopoiesis, a process that
was more prominently disturbed by Birc5b depletion.
Nonetheless, administration of either mRNA could effec-
tively rescue the phenotypes induced by depletion of the
other. Thus, the physiologic relevance of the functional
differences between the two survivin paralogs is not fully
delineated, and it appears that each may act to compen-
sate for deficiencies of the other.
A common feature of both Birc5 genes, not previously rec-
ognized, is that their expression in the somites and axial
vessels is transient and restricted to an early developmen-
tal time period, both essentially gone by 3 dpf. Up until
that time, the axial vessels and the ISVs are generated, and
based on the morpholino knockdowns, survivin is critical
for formation of these structures, after which survivin isPage 10 of 17
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Apoptosis in Birc5-depleted embryosFigure 6
Apoptosis in Birc5-depleted embryos. Tg(Fli:eGFP) embryos reveal apoptosis (red) in relation to blood vessels (green) (A-
O). A-I: Morphants at 1 dpf exhibit increased apoptosis, particularly in the brain (B) and along neural tube (E) in Birc5a mor-
phants (morpholino dose 2 ng). Birc5b depletion with 4 ng of morpholino caused apoptosis in axial vessel region, caudal vein 
plexus, and neural structures (C, F). G-I: Confocal microscopy of 1 μm sagittal "slice" in region of caudal vein plexus and corre-
sponding neural tube (excludes somites): Dose-dependent changes in apoptosis in caudal vein plexus region (J, region II) and 
corresponding neural tissue (J, region I) after Birc5 knockdowns was quantified at 1 dpf. High dose Birc5a morpholino (2 ng) or 
Birc5b morpholino (4 ng) causes significant increase in apoptosis in caudal vein plexus and neural tube (K, L). With lower Birc5a 
morpholino dose 0.5 ng), neural tube apoptosis remains significantly increased, but is almost absent in caudal vein plexus (N). 
Low dose Birc5b morpholino (1.0 ng) causes significant apoptosis in caudal vein plexus, but not in neural tube (O). Data pre-
sented in bottom panel. n = 30 × 3 independent experiments. * p < 0.05 relative to corresponding control. mhc: midbrain-hind-
brain channel, aa: aortic arch, ax: axial vessels, cv: caudal vein plexus.
BMC Developmental Biology 2009, 9:25 http://www.biomedcentral.com/1471-213X/9/25no longer necessary at those sites. Interestingly, the IAP
Birc2 is expressed in the vasculature of zebrafish begin-
ning at 54 hpf, whereupon it is required to maintain
endothelial cell integrity [40]. One could speculate that
there exists an intrinsic molecular switch that is "flipped"
at 2–3 dpf, when Birc5 expression turns off, and Birc2
turns on, the latter which is required to form a more com-
plex vascular network. Characterization of such a switch
mechanism could enhance our understanding of the reg-
ulation of angiogenesis.
In mice depleted of endothelial survivin, embryonic heart
development was abnormal, and the mutant endocardial
lineage cells could not support epithelial-mesenchymal
transformation (EMT) [14]. In both survivin gene knock-
downs in the zebrafish, we also observed abnormalities in
cardiogenesis – more prominent with Birc5a depletion.
Fate-mapping studies in zebrafish have revealed that for-
mation of the atrium, ventricle and a-v valves depends on
the integrity of the cardiac neural crest cells [36], while
intracardiac fluid forces also contribute to normal heart
development [33]. Thus, the etiology of the abnormalities
in cardiogenesis in the Birc5 morphants may be multifac-
torial, i.e. secondary to the circulation defect and/or due
to loss of the cardiac neural crest cells. Further study is
required to elucidate the relevant Birc5-dependent pro-
survival pathways for these neural crest cells. Nonetheless,
the zebrafish and mouse models highlight the importance
of survivin in heart development. Just as single-nucleotide
polymorphisms of the VEGF gene have been linked to
congenital valvuloseptal defects [41], the possibility that
functional alterations in survivin expression might under-
lie congenital heart defects is worthy of consideration.
The prominent role that survivin plays in regulating vas-
culo-angiogenesis, neurogenesis, cardiogenesis and
hematopoiesis supports the widely accepted notion of co-
ordinately regulated development of these systems
(reviewed in [42]). For example, the Eph/ephrins regulate
fasciculation and guidance of axons, direct neural crest
cell fate and migration, modulate neural progenitor cell
survival, while also being important for cardiovascular
development [43] and erythropoiesis [44]. Vascular
endothelial growth factor (VEGF), although best charac-
terized as a critical mediator of vasculogenesis and angio-
genesis, also has direct effects on the nervous system
(reviewed in [45]). VEGF protects neural cells from
hypoxia, facilitates axonal outgrowth, promotes endothe-
lial release of neurogenic factors [46], and induces neural
stem cell proliferation [47]. VEGF also promotes hemat-
opoiesis [48], and altered regulation of VEGF results in
profound defects in heart development [49]. These prop-
erties of VEGF are confirmed in our studies, where the
neural and cardiovascular phenotypes induced by deple-
tion of Birc5a or Birc5b, were rescued by VEGF. Although
not tested, it is likely that upon depletion of one Birc5
gene, the exogenous VEGF upregulated expression of the
other, which in turn compensated for the phenotypic
defects. In that respect, Ma et al [37] indeed, demon-
strated that VEGF protein can increase accumulation of
Birc5a mRNA in zebrafish embryos. Beyond the zebrafish
model system, upregulation of survivin in endothelial
cells has been well-documented [37]. The finding that sur-
vivin is also a downstream effector of VEGF in the neuro-
logic system, and that survivin transcripts are highly
expressed in neural progenitor cells [50], implies that the
survivin gene in humans may, similar to VEGF [51], be a
modifier in the progression of neural diseases, such as
amyotrophic lateral sclerosis, and thus have the potential
as a therapeutic target.
By regulating cell proliferation and apoptosis, the two
zebrafish survivin genes, Birc5a and Birc5b, play important
roles in multiple biologic systems. Although we have not
examined all organs during development; nor have we yet
evaluated its role in the eye; the prominent effects of Birc5
gene depletion on the cardiac, neurovascular and hemat-
opoietic systems in the zebrafish embryo suggest that sur-
vivin has temporal and tissue-specific properties. In view
of the apparent functional overlap with the murine and
human survivin orthologues, the zebrafish model pro-
vides an exceptional opportunity to examine the physio-
logic relevance of the complex molecular and biochemical
pathways that govern cell survival and apoptosis. The
insights gained will lead to the development of safer, tar-
geted therapeutics for a spectrum of cardio-vascular,
hematopoeitic and neurologic diseases, and a better
understanding of the etiology and genetics of an array of
congenital diseases.
Methods
Zebrafish strains and maintenance
Wild-type AB zebrafish and Tg(Flk1:EGFP),
Tg(Fli:EGFP)y1, and Tg(gata1:GFP) zebrafish were main-
tained under standard laboratory conditions [22].
Embryos were grown in 0.003% 1-phenyl-2-thiourea
(PTU, Sigma, Bornem, Belgium) in 0.3× Danieau (17 mM
NaCl, 0.21 mM KCl, 0.12 mM MgSO4.7H2O, 0.18
mMCa(NO3)2, 1.5 mM Hepes (Fluka, Bornem, Belgium)
pH 7.6) starting from 24 hpf, were kept at 28.5°C, and
staged according to standard criteria [52]. After 24 hours,
the chorion was removed with trypsin 1.5 mg/ml (Sigma).
All animal studies were approved by the University of Leu-
ven Animal Studies Ethics Commission.
Digoxigenin-labeled RNA probes for in situ hybridization
cDNAs were cloned into the pGEM-T Easy vector (Promega,
Leiden, the Netherlands). For detection of Birc5a, primer
pairs: Birc5a-F1/R1, Birc5a-F2/R2 and Birc5a-F3/R3 (see
Additional file 2) were used to generate amplicons, respec-
tively, of 902 bp (3' coding region + UTR), 344 bp (only 3'
UTR) and 429 bp (coding region). For detection of Birc5b,Page 12 of 17
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Cell proliferation in Brc5-depleted embryosFigure 7
Cell proliferation in Brc5-depleted embryos. Tg(Fli:eGFP) embryos, were used to localize proliferating cells (red, A-F) in 
relation to blood vessels (green, A'-F') after Birc5 morpholino knockdowns. Proliferating cells immuno-detected by whole-
mount staining of 2 dpf embryos with anti-phospho-Histone H3 antibodies (red). The number of proliferating cells in the caudal 
vein plexus and neural tube (see Figure 6J for regions) was quantified in embryos after high dose (B, C) or low dose (E, F) mor-
pholino knockdowns. With high dose Birc5a or Birc5b morpholino (2 ng or 4 ng, respectively), there is a significant decrease in 
cell proliferation in the caudal vein plexus and the neural tube (B, C) as compared to the control (A). When the Birc5a mor-
pholino knockdown dose is lowered (0.5 ng) (E), there is still a significant decrease in cell proliferation in the neural tube, but 
not in the caudal vein plexus, compared to control (D). Conversely, low dose Birc5b morpholino knockdown (1.0 ng) results in 
a significant diminution of cell proliferation in the caudal vein plexus, but not in the neural tube (F). Quantitative data are pre-
sented in the bottom panel. n = 30 × 3 independent experiments. * p < 0.05 relative to corresponding control.
BMC Developmental Biology 2009, 9:25 http://www.biomedcentral.com/1471-213X/9/25probes were made with the following primer pairs: Birc5b-
F1/R1 and Birc5b-F2/R2, generating amplicons, respec-
tively, of 491 bp (coding region + 3' UTR) and 387 bp (cod-
ing region). After linearization with Spe1 and Nco1,
antisense riboprobes were prepared with the DIG RNA
labeling kit (Roche, Vilvoorde, Belgium) according to the
manufacturer's instructions and purified with the RNeasy
mini kit (Qiagen, Venlo, the Netherlands).
Flow cytometry
Tg(Gata1:GFP) zebrafish embryos were injected at the 1-
cell stage, and at 14 hpf, they were dechorionated and
digested with 0.05% trypsin/EDTA for 15 minutes at
28°C. A single cell suspension was obtained by pipetting
up and down, after which 100% fetal calf serum (FCS)
was added. Cells were filtered through a 40 μM cell
strainer, washed with 2% FCS/PBS, and the percentage of
GFP-positive cells was measured by flow cytometry (Facs-
Calibur, BD Biosciences).
mRNA preparation
cDNAs in plasmid vectors were linearized with the appro-
priate restriction enzyme, and the digested DNA was eth-
anol precipitated. mRNA for each survivin gene transcript
Table 1: Rescue of neuro-vascular phenotypes with Birc5 mRNAs
Buffer or Specific mRNA Co-injected




















Birc5 morpholinos were injected into Tg(Fli:eGFP) zebrafish embryos simultaneously with injections of specific mRNAs as shown, and phenotypic 
analyses were performed at 2 dpf. The incidence of neural or vascular abnormalities is illustrated.
Rescue of Birc5 knockdown phenotypes with VEGF mRNAFigur  8
Rescue of Birc5 knockdown phenotypes with VEGF mRNA. Birc5a or Birc5b was depleted with 2 ng or 4 ng, respec-
tively, of corresponding morpholino into Tg(Fli:eGFP) embryos, alone or with human VEGF mRNA. Embryos were evaluated at 
2 dpf. Morpholino-induced angiogenic, cardiac and neurodevelopmental defects were reversed by VEGF.Page 14 of 17
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instructions (Ambion, Lennik, Belgium).
Real-time PCR
Quantitative real-time PCR was performed to examine the
expression of different hematopoietic genes using SYBR
green (Applied Biosystems, Belgium) according to manu-
facturers instructions. The sequence of the oligonucle-
otide primers used are as reported by Ma et al [29]. The β-
actin mRNA levels were used as an internal reference.
Morpholino and mRNA injection
Morpholinos (Gene Tools LLC, Oregon, USA) were tar-
geted against the ATG or 5'UTR of Birc5a and Birc5b. Mor-
pholinos and synthetic mRNAs were diluted in 1.5%
phenol red (Sigma) in 0.2 M KC. Fertilized zebrafish eggs
at the 1–4 cell stage were positioned into agar slots, and
using a Femtojet (Eppendorf, Haasrode, Belgium), a
micromanipulator (Narishige, New York, USA) and a
Zeiss-stemi 2000-C light microscope (Zeiss, Zaventum,
Belgium), eggs were injected with 1 nl of morpholino
using back-filled fine borosilicate, glass capillary needles.
Detection of apoptosis and cell proliferation
Embryos were fixed in 4% paraformaldehyde overnight at
4°C and stored in methanol at -20°C until further processing.
In situ hybridization was performed as described [17]. For
apoptosis and cell proliferation studies, embryos were first
rehydrated with decreasing concentrations of methanol,
washed with PBST (PBS, 0.1% Tween 20), treated with protei-
nase K (10 mg/ml) at 37°C for 30 to 60 minutes, refixed with
4% paraformaldehyde, washed in PBST, and lastly incubated
with 0.1 M citrate solution (0.1% citrate/PBS/Triton). TUNEL
staining was performed with the ApopTag kit (Chemicon,
Heule, Belgium). Cell proliferation was visualized using anti-
bodies against phosphorylated phospho-histone H3 (Upstate,
Huissen, the Netherlands). After mounting in 3% methylcel-
lulose (Sigma) in PBS, embryos were visualized by light
microscopy or with a Zeiss Lumar fluorescence stereomicro-
scope, and pictures were taken under green fluorescence
Tg(Fli:eGFP) and red fluorescence (apoptotic cells or prolifer-
ating cells) with a Zeiss AxioCam MRc digital camera. For each
embryo, the entire caudal vein plexus and corresponding over-
lying neural tube was delineated, and apoptotic cells or prolif-
erating cells were manually counted. 30 embryos were
analyzed per condition and 3 experiments were performed.
Data were compared with a standard Student t-test.
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A. Using the CLUSTAL W program, protein sequences of human, 
mouse, Xenopus and zebrafish survivin were aligned.B. The overall 
similarity (in %) at the level of amino acid sequence between survivins of 
human, mouse, Xenopus and zebrafish were compared. Homo, Homo 
sapiens; Mus, Mus musculus; XT, Xenopus tropicalis; Birc5, danio 
rerio; XL, Xenopus laevis; * identical amino acid; conserved change; 
highly conserved change.





Primers used to generate in situ hybridization probes.





Morpholinos used for the knockdown of Birc5a and Birc5b.




Specificity of Birc5 morpholinos. 
An oligonucleotide for each zebrafish survivingene containing the 
binding sites of the different morpholinos directed against the 5' UTR 
and the ATG of each gene, was cloned into the pCAG-T7-luciferase 
plasmid, resulting in the pCAG-T7-luciferase-Birc5a and pCAG-T7-
luciferase-Birc5b plasmids. These plasmids, together with varying doses 
of Birc5 morpholinos, were used in an in vitrotranscription/translation 
assay, as described [18]. Experiments were performed in triplicate. Luci-
ferase activity was measured in arbitrary light units that are noted in the 
Y-axis. Birc5a is only depleted by the Birc5a morpholino (B-F) and not 
by the Birc5b morpholino (G-K). Similarly, Birc5b is only depleted by the 
Birc5b morpholino (R-V) and not by the Birc5a morpholino (M-Q). 
Birc5a plasmid: pCAG-T7-luciferase-Birc5a; Birc5b plasmid: pCAG-T7-
luciferase-Birc5b; MO1: Birc5a morpholino; MO2: Birc5b morpholino.




Tg(Flk1:GFP) control-injected embryo at 3 dpf.
Confocal microscopy was used to visualize a cross sectional view from 
the of top of the head region of a 3 dpf zebrafish embryo, revealing the 
different vascular structures.
Click here for file
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Tg(Flk1:GFP) Birc5a morphant embryo at 3 dpf. 
When compared to the control (Movie S1), depletion of Birc5a with 
2 ng of morpholino results in striking underdevelopment and irregu-
lar patterning of several blood vessels in the head of the embryo.




Tg(Flk1:GFP) Birc5b morphant embryo at 3 dpf. 
When compared to the control (Movie S1), knockdown of Birc5b with 
4 ng of morpholino leads to underdevelopment of vascular structures 
in the head, although to a lesser extent than in the Birc5a morphants 
(Movie S2).
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